Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 5221 AL 5235

Cholesterol Metabolism in Neurodegenerative Diseases

He K, Zhao Z, Zhang J, Li D, Wang S, Liu Q.

Antioxid Redox Signal. 2024 Dec;41(16-18):1051-1072. doi: 10.1089/ars.2024.0674. Epub 2024 Jul 11.

Treatments and Outcomes Among Patients with Sydenham Chorea: A Meta-Analysis

Eyre M, Thomas T, Ferrarin E, Khamis S, Zuberi SM, Sie A, Newlove-Delgado T, Morton M, Molteni E, Dale RC, Lim M, Nosadini M; Sydenham’s Chorea Systematic Literature Review Working Group.

JAMA Netw Open. 2024 Apr 1;7(4):e246792. doi: 10.1001/jamanetworkopen.2024.6792.

Fueling neurodegeneration: metabolic insights into microglia functions

Sadeghdoust M, Das A, Kaushik DK.

J Neuroinflammation. 2024 Nov 17;21(1):300. doi: 10.1186/s12974-024-03296-0.

Purinergic-associated immune responses in neurodegenerative diseases

Carracedo S, Launay A, Dechelle-Marquet PA, Faivre E, Blum D, Delarasse C, Boué-Grabot E.

Prog Neurobiol. 2024 Dec;243:102693. doi: 10.1016/j.pneurobio.2024.102693. Epub 2024 Nov 22.

Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study

Gao L, Bhattacharyya A, Beers B, Kaushik D, Bredlau AL, Kristensen A, Abd-Elaziz K, Grant R, Golden L, Kong R.

Br J Clin Pharmacol. 2024 Dec;90(12):3242-3251. doi: 10.1111/bcp.16202. Epub 2024 Aug 18.

Chorea-acanthocytosis

Rashid S, Malek N, Krommyda M.

Pract Neurol. 2024 May 29;24(3):223-225. doi: 10.1136/pn-2023-003981.

The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

Köhler TS, Kloner RA, Rosen RC, Burnett AL, Blaha MJ, Ganz P, Goldstein I, Kim NN, Lue T, McVary KT, Mulhall JP, Parish SJ, Sadeghi-Nejad H, Sadovsky R, Sharlip ID, Miner M.

Mayo Clin Proc. 2024 Sep;99(9):1500-1517. doi: 10.1016/j.mayocp.2024.06.002. Epub 2024 Aug 8.

Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics

Acharya P, Choi NY, Shrestha S, Jeong S, Lee MY.

Biotechnol Bioeng. 2024 Feb;121(2):489-506. doi: 10.1002/bit.28606. Epub 2023 Nov 28.

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions

Gu YY, Zhao XR, Zhang N, Yang Y, Yi Y, Shao QH, Liu MX, Zhang XL.

Ageing Res Rev. 2024 Dec;102:102577. doi: 10.1016/j.arr.2024.102577. Epub 2024 Nov 10.

Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health

Cocean AM, Vodnar DC.

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30;134:111073. doi: 10.1016/j.pnpbp.2024.111073. Epub 2024 Jun 22.

The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review

Nakhal MM, Yassin LK, Alyaqoubi R, Saeed S, Alderei A, Alhammadi A, Alshehhi M, Almehairbi A, Al Houqani S, BaniYas S, Qanadilo H, Ali BR, Shehab S, Statsenko Y, Meribout S, Sadek B, Akour A, Hamad MIK.

Life (Basel). 2024 Sep 26;14(10):1234. doi: 10.3390/life14101234.

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Guo D, Liu Z, Zhou J, Ke C, Li D.

Int J Mol Sci. 2024 Sep 15;25(18):9947. doi: 10.3390/ijms25189947.

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Xiang Y, Song X, Long D.

Arch Toxicol. 2024 Mar;98(3):579-615. doi: 10.1007/s00204-023-03660-8. Epub 2024 Jan 24.

The Formation and Function of the VTA Dopamine System

Hou G, Hao M, Duan J, Han MH.

Int J Mol Sci. 2024 Mar 30;25(7):3875. doi: 10.3390/ijms25073875.

Copper homeostasis and cuproptosis in central nervous system diseases

Zhu Z, Song M, Ren J, Liang L, Mao G, Chen M.

Cell Death Dis. 2024 Nov 21;15(11):850. doi: 10.1038/s41419-024-07206-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias